Anthony P. Bihl III - 18 Aug 2023 Form 4 Insider Report for Bioventus Inc. (BVS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
22 Aug 2023, 18:20:27 UTC
Prior SEC filing
20 Jun 2023
Next SEC filing
19 Sep 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Anthony D'Adamio, Attorney-in-Fact

Key filing fact

Anthony P. Bihl III filed Form 4 for Bioventus Inc. (BVS) on 22 Aug 2023.

Key facts

  • This page summarizes Anthony P. Bihl III's Form 4 filing for Bioventus Inc. (BVS).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 22 Aug 2023, 18:20.

Change

  • Previous filing in this sequence was filed on 20 Jun 2023.
  • Current net transaction value: +$165,076.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BVS transaction

Class A Common Stock

Purchase

Transaction value
$55,005
Shares
+13,290
Change %
+11%
Price
$4.14
Shares after
138,290
Date
18 Aug 2023
Ownership
Direct
Footnotes
F1
BVS transaction

Class A Common Stock

Purchase

Transaction value
$110,071
Shares
+26,595
Change %
Price
$4.14
Shares after
26,595
Date
18 Aug 2023
Ownership
By Spouse's Trust
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $3.89 to $4.405, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Footnote F2

Reflects shares directly held by The Irene A. Bihl Revocable Trust of which the Reporting Person and his spouse are trustees and among the beneficiaries. The Reporting Person disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .